Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06428539

T Regulatory Cells IN LUPUS NEPHRITIS

T Regulatory Cells in Lupus Nephritis

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
65 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

* To study the role FoxP3-positive T regulatory cells in the pathogenesis of Lupus Nephritis, and determine the factors associated with levels of T regs . * To compare the functional capacity of T regs in LN and in normal individuals.

Detailed description

Lupus Nephritis (LN) encompasses a group of glomerulonephrites, that occur in association with systemic lupus erythematosus (SLE). The mainstream theory that it is an immune disease resulting from loss of immune tolerance against body cells. The regulatory T cells (T regs ) are a subpopulation of immune cells that maintain tolerance to self-antigens and suppress autoimmune diseases. The main marker of Tregs is FoxP3 (forkhead box protein 3) positivity. Moreover, It has been suggested that functional capacity of Tregs is also compromised in autoimmune diseases. Studying the role of T regs in LN is a promising field that can help tailor current immune therapy and develop new treatment strategies.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTT-reg cellslaboratory test

Timeline

Start date
2024-07-01
Primary completion
2025-07-01
Completion
2025-08-01
First posted
2024-05-24
Last updated
2024-05-29

Source: ClinicalTrials.gov record NCT06428539. Inclusion in this directory is not an endorsement.